# OSCAR II STUDY - The ONCObind CTC Removal Study

> **NCT06655142** · NA · NOT_YET_RECRUITING · sponsor: **ExThera Medical Corporation** · enrollment: 120 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (mPDAC)
- Metastatic Colorectal Carcinoma (mCRC)

## Interventions

- **DEVICE:** ONCObind (Onco-Seraph) 100 Filter
- **OTHER:** Matched Controls

## Key facts

- **NCT ID:** NCT06655142
- **Lead sponsor:** ExThera Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-15
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655142, "OSCAR II STUDY - The ONCObind CTC Removal Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06655142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*